South & Central America dPCR and qPCR Market Forecast to 2030 - Regional Analysis - By Treatment [Quantitative PCR (qPCR) and Digital PCR (dPCR)], Product (Reagents & Consumables, Instruments, and Software & Services), Application (Research Application, Clinical Application, and Forensic Application), and End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organizations)

BMIRE00029882 | Pages: 94 | Biotechnology | Mar 2024 | Type: Regional | Status: Published

The South & Central America dPCR and qPCR market was valued at US$ 579.36 million in 2022 and is expected to reach US$ 974.29 million by 2030; it is estimated to grow at a CAGR of 6.7% from 2022 to 2030.

Growing Adoption of PCR Methods in Emerging Countries Drive South & Central America dPCR and qPCR Market

In recent years, molecular methods such as PCR have evolved as diagnostic technology. The method enables healthcare professionals to diagnose a wide range of infectious diseases accurately and is considered an indispensable research and diagnostic tool. PCR allows the generation of millions of DNA copies from one single strand of DNA. It also allows early diagnosis of disease and hence plays an essential role in disease control. PCR gives reproducible results that are comparable between different laboratories and hence are accepted worldwide. As PCR techniques are being widely accepted and utilized in emerging countries. Due to its simple, rapid, and highly specific screening of diseases and its increasing application in clinical microbiology, virology, parasitology, biotechnology, and allied fields, the South & Central America dPCR and qPCR market in developing countries is expected to experience lucrative opportunities during the forecast period.

South & Central America dPCR and qPCR Market Overview

Cancer is one of the significant causes of mortality in Brazil. In the last few years, cancer cases have increased across the country. According to Revista Brasileira de Cancerologia, in 2023, there will be 7.04 million new cases of cancer in Brazil. Further, dPCR and qPCR are major tools for cancer diagnosis, and technological advancements in these tools enhance the diagnosis. Also, the increasing incidence of yellow fever is a public health concern in Brazil. Three countries in the Americas reported confirmed cases of yellow fever in 2022 between epidemiological week (EW) 1 and EW 52: Bolivia (5 confirmed cases), Brazil (5 cases and 4 deaths during the seasonal period of 2021-2022), and Peru (7 confirmed cases, including 5 deaths). dPCR and qPCR methods offer rapid, sensitive, and highly specific detection of the yellow fever virus. Thus, an increase in cancer and yellow fever cases bolster the deployment of dPCR and qPCR solutions across Brazil.

South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Million)

South & Central America dPCR and qPCR Market Segmentation

The South & Central America dPCR and qPCR market is segmented based on treatment, product, application, end user, and country.

Based on treatment, the South & Central America dPCR and qPCR market is bifurcated into quantitative PCR (qPCR) and digital PCR (dPCR). The digital PCR (dPCR) segment held a larger share in 2022.

By product, the South & Central America dPCR and qPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share in 2022.

By application, the South & Central America dPCR and qPCR market is segmented into research application, clinical application, and forensic application. The clinical application segment held the largest share in 2022. The clinical application segment is further subsegmented into oncology testing, blood screening, infectious disease testing, and other applications.

By end user, the South & Central America dPCR and qPCR market is segmented into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and diagnostic centers segment held the largest share in 2022.

Based on country, the South & Central America dPCR and qPCR market is segmented into segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America dPCR and qPCR market in 2022.

Abbott Laboratories, Agilent Technologies Inc, Bio-Rad Laboratories Inc, F. Hoffmann-La Roche Ltd, Qiagen NV, Standard BioTools Inc, Takara Bio Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the South & Central America dPCR and qPCR market.

Table of Content

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South & Central America dPCR and qPCR Market Landscape

4.1 Overview

4.2 South & Central America PEST Analysis

5. South & Central America dPCR and qPCR Market - Key Industry Dynamics

5.1 Market Drivers

5.1.1 Increasing Incidence of Genetic and Infectious Diseases

5.1.2 Rising Investments and Funds for Gene Synthesis

5.1.3 Technological Advancements in PCR Technologies

5.2 Market Restraints

5.2.1 High Costs of PCR Systems

5.2.2 Technical Limitations Associated with qPCR

5.3 Market Opportunities

5.3.1 Growing Adoption of PCR Methods in Emerging Countries

5.4 Future Trends

5.4.1 Development of Droplet Digital PCR

5.5 Impact Analysis:

6. dPCR and qPCR Market - South & Central America Market Analysis

6.1 South & Central America dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030

7. South & Central America South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 - by Treatment

7.1 Overview

7.2 South & Central America dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)

7.3 Quantitative PCR

7.3.1 Overview

7.3.2 Quantitative PCR: South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Digital PCR

7.4.1 Overview

7.4.2 Digital PCR: South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 - by Product

8.1 Overview

8.2 South & Central America dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)

8.3 Reagents & Consumables

8.3.1 Overview

8.3.2 Reagents & Consumables: South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Instruments

8.4.1 Overview

8.4.2 Instruments: South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Software & Services

8.5.1 Overview

8.5.2 Software & Services: South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 - by Application

9.1 Overview

9.2 South & Central America dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)

9.3 Research Application

9.3.1 Overview

9.3.2 Research Application: South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

9.4 Clinical Application

9.4.1 Overview

9.4.2 Clinical Application: South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

9.4.2.1 South & Central America dPCR and qPCR Market, by Clinical Application, 2020-2030 (US$ Million)

9.5 Forensic Application

9.5.1 Overview

9.5.2 Forensic Application: South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 - by End-User

10.1 Overview

10.2 South & Central America dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)

10.3 Hospitals and Diagnostic Centers

10.3.1 Overview

10.3.2 Hospitals and Diagnostic Centers: South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

10.4 Pharmaceutical and Biotechnology Companies

10.4.1 Overview

10.4.2 Pharmaceutical and Biotechnology Companies: South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

10.5 Research Laboratories and Academic Institutes

10.5.1 Overview

10.5.2 Research Laboratories and Academic Institutes: South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

10.6 Forensic Laboratories

10.6.1 Overview

10.6.2 Forensic Laboratories: South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

10.7 Clinical Research Organizations

10.7.1 Overview

10.7.2 Clinical Research Organizations: South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

11. South & Central America dPCR and qPCR Market - Country Analysis

11.1.1.1 South & Central America dPCR and qPCR Market, by Country

11.1.1.2 Brazil

11.1.1.2.1 Brazil: South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.2.2 Brazil: South & Central America dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)

11.1.1.2.3 Brazil: South & Central America dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)

11.1.1.2.4 Brazil: South & Central America dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)

11.1.1.2.4.1 Brazil: South & Central America dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)

11.1.1.2.5 Brazil: South & Central America dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)

11.1.1.3 Argentina

11.1.1.3.1 Argentina: South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.3.2 Argentina: South & Central America dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)

11.1.1.3.3 Argentina: South & Central America dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)

11.1.1.3.4 Argentina: South & Central America dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)

11.1.1.3.4.1 Argentina: South & Central America dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)

11.1.1.3.5 Argentina: South & Central America dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)

11.1.1.4 Rest of South & Central America

11.1.1.4.1 Rest of South & Central America: South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)

11.1.1.4.2 Rest of South & Central America: South & Central America dPCR and qPCR Market, by Treatment, 2020-2030 (US$ Million)

11.1.1.4.3 Rest of South & Central America: South & Central America dPCR and qPCR Market, by Product, 2020-2030 (US$ Million)

11.1.1.4.4 Rest of South & Central America: South & Central America dPCR and qPCR Market, by Application, 2020-2030 (US$ Million)

11.1.1.4.4.1 Rest of South & Central America: South & Central America dPCR and qPCR Market, for Clinical Application by Application, 2020 - 2030 (US$ Million)

11.1.1.4.5 Rest of South & Central America: South & Central America dPCR and qPCR Market, by End-User, 2020-2030 (US$ Million)

12. dPCR and qPCR Market-Industry Landscape

12.1 Overview

12.2 Growth Strategies in South & Central America dPCR and qPCR Market

12.3 Organic Growth Strategies

12.3.1 Overview

12.4 Inorganic Growth Strategies

12.4.1 Overview

13. Company Profiles

13.1 Abbott Laboratories

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Thermo Fisher Scientific Inc

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Takara Bio Inc

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Qiagen NV

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Standard BioTools Inc

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 F. Hoffmann-La Roche Ltd

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Bio-Rad Laboratories Inc

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Agilent Technologies Inc

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

14. Appendix

14.1 About Us

14.2 Glossary of Terms

 

 

 

List of Tables

Table 1. South & Central America dPCR and qPCR Market Segmentation

Table 2. South & Central America dPCR and qPCR Market, by Clinical Application - Revenue and Forecast to 2030 (US$ Million)

Table 3. Brazil: South & Central America dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)

Table 4. Brazil: South & Central America dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 5. Brazil: South & Central America dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 6. Brazil: South & Central America dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)

Table 7. Brazil: South & Central America dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)

Table 8. Argentina: South & Central America dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)

Table 9. Argentina: South & Central America dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 10. Argentina: South & Central America dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 11. Argentina: South & Central America dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)

Table 12. Argentina: South & Central America dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)

Table 13. Rest of South & Central America: South & Central America dPCR and qPCR Market, by Treatment - Revenue and Forecast to 2030 (US$ Million)

Table 14. Rest of South & Central America: South & Central America dPCR and qPCR Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 15. Rest of South & Central America: South & Central America dPCR and qPCR Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 16. Rest of South & Central America: South & Central America dPCR and qPCR Market, for Clinical Application by Application - Revenue and Forecast to 2030 (US$ Million)

Table 17. Rest of South & Central America: South & Central America dPCR and qPCR Market, by End-User - Revenue and Forecast to 2030 (US$ Million)

Table 18. Recent Organic Growth Strategies in South & Central America dPCR and qPCR Market

Table 19. Recent Inorganic Growth Strategies in the South & Central America dPCR and qPCR Market

Table 20. Glossary of Terms, South & Central America dPCR and qPCR Market

 

List of Figures

Figure 1. South & Central America dPCR and qPCR Market Segmentation, By Country

Figure 2. South & Central America - PEST Analysis

Figure 3. South & Central America dPCR and qPCR Market - Key Industry Dynamics

Figure 4. Impact Analysis of Drivers and Restraints

Figure 5. South & Central America dPCR and qPCR Market Revenue (US$ Mn), 2022 - 2030

Figure 6. South & Central America dPCR and qPCR Market Revenue Share, by Treatment, 2022 & 2030 (%)

Figure 7. Quantitative PCR: South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Digital PCR: South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. South & Central America dPCR and qPCR Market Revenue Share, by Product, 2022 & 2030 (%)

Figure 10. Reagents & Consumables: South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Instruments: South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Software & Services: South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. South & Central America dPCR and qPCR Market Revenue Share, by Application, 2022 & 2030 (%)

Figure 14. Research Application: South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Clinical Application: South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Forensic Application: South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. South & Central America dPCR and qPCR Market Revenue Share, by End-User, 2022 & 2030 (%)

Figure 18. Hospitals and Diagnostic Centers: South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Pharmaceutical and Biotechnology Companies: South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Research Laboratories and Academic Institutes: South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Forensic Laboratories: South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Clinical Research Organizations: South & Central America dPCR and qPCR Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. South & Central America dPCR and qPCR Market, by Key Country - Revenue, 2022 (US$ Million)

Figure 24. South & Central America dPCR and qPCR Market, By Key Countries, 2022 and 2030 (%)

Figure 25. Brazil: South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)

Figure 26. Argentina: South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)

Figure 27. Rest of South & Central America: South & Central America dPCR and qPCR Market Revenue and Forecast to 2030 (US$ Mn)

Figure 28. Growth Strategies in South & Central America dPCR and qPCR Market

1. Abbott Laboratories

 

2. Thermo Fisher Scientific Inc

3. Takara Bio Inc

4. Qiagen NV

5. Standard BioTools Inc

6. F. Hoffmann-La Roche Ltd

7. Bio-Rad Laboratories Inc

8. Agilent Technologies Inc

 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America dPCR and qPCR market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in South & Central America dPCR and qPCR market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the dPCR and qPCR market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440